The in vitro metabolism of LC15-0133, a novel dipeptidyl peptidase-4 (DPP-4) inhibitor, was investigated using a hepatic microsomal system. The structures of the metabolites were characterized using mass spectral analysis and by comparison with synthetic references. The in vitro incubation of LC15-0133 with rat liver microsomes resulted in the formation of six metabolites, with the major metabolic reactions being hydroxylation and carbonyl reduction. Of the metabolites, a C-demethylated metabolite (M4) was identified, but was only detected in rat liver microsomes; experimental evidence revealed that the C-demethylated metabolite was generated by non-enzymatic decarboxylation of the carboxyl metabolite (M1). Non-enzymatic decarboxylation is postulated to occur due to the resonance stabilization by the oxadiazole ring attached to the tert-butyl moiety.
(DPP-4) inhibitor, is under development as a therapeutic agent for diabetes. DPP-4
inhibitors have been characterized to lower blood glucose in diabetic rodents via prolongation of glucagon-like peptide-1 (GLP-1) and the action of gastric inhibitory polypeptide (GIP) (Ahren and Schmitz, 2004; Demuth et al., 2005; Barnett, 2006; Campbell, 2007; Pratley and Salsali, 2007) .
As a part of the pre-clinical study of LC15-0133, the in vitro metabolism of LC15-0133 was investigated using rat, dog and human liver microsomes. LC15-0133 was metabolized to 4-6 metabolites, via hydroxylation and carbonyl reduction, with considerable species difference noted in rat liver microsomes. C-demethylated and carboxy metabolites were observed only in the rat liver microsomal incubation. Because the C-demethylation reaction is not a common enzymatic reaction, the metabolic pathway for the generation of the C-demethylated metabolite requires further investigation.
The purpose of the present study was to characterize the in vitro metabolism of LC15-0133 and identify the mechanism of the rat liver microsomal enzyme catalyzed LG Life Sciences R&D (Daejon, Korea). All other chemicals were the highest grade commercially available.
Microsomes. Human liver microsomes were purchased from BD Biosciences (MA, USA). Rat liver samples were taken from Sprague-Dawley rats (Daehan Animal, Daejeon, Korea) and dog liver samples from Beagle dogs (Daehan Animal, Daejeon, Korea). The microsomal fraction was prepared according to the method previously described elsewhere (Guengerich et al., 1986) .
In vitro microsomal incubation. LC15-0133 (100 μ M final concentration) was incubated with 2 mg/mL liver microsomes, at 37 ºC for 2 hr, in the presence of an NADPH generating system (10 mM glucose 6-phosphate, 0.67 mM β-NADP + and 1 U/ml glucose 6-phosphate dehydrogenase), in a final incubation volume of 200 228. This metabolite was postulated to be a carboxylic acid derivative generated due to further oxidation of M3. The product ion at m/z 357 was postulated to have been generated due to dissociation of a carboxyl moiety from the protonated molecular ion.
The MS 3 spectrum of the ion at m/z 357 was consistent with the MS 2 spectrum of M4,
the C-decarboxylated metabolite (Fig 2B and 2C suggesting that this metabolite was a demethylated derivative. All the product ions were also 14 Da less than the corresponding ions of the parent compounds, suggesting demethylation had occurred at the tert-butyl moiety. The structure of M4 was confirmed by comparison with a synthetic standard.
The structure of M4 was somewhat unexpected, as C-demethylation is not common during metabolism; whereas, O-and N-demethylations are frequently observed in the biotransformation of xenobiotics (Coutts et al., 1994; Burke et al., 1994; Ertl et al., 1999) . In case of terfenadine possessing a tert-butyl moiety on the backbone of the
compound, similarly to LC15-0133, both alcohol and acid metabolites have been identified, but the C-demethylated metabolite has never been reported (Jurima-Romet et al., 1994; Terhechte and Blaschke, 1995; Ling et al., 1995; Rodrigues et al., 1995) .
Initially, it was postulated that M4 was able to be generated via the sulfate conjugate of M1, from which the carboxyl sulfate moiety might easily be dissociated. However, this possibility was ruled out as not even trace amount of a sulfate conjugate was detected in the incubation along with phosphoadenosyl phosphosulfate (data not shown).
It was subsequently hypothesized that the C-demethylated metabolite (M4) could be spontaneously generated from the acid metabolite (M1) via decarboxylation, where the removal of the carboxyl group was attributed to the oxadiazole ring attached to the tertbutyl moiety. To test this hypothesis, the acid metabolite (M1) was collected using preparative HPLC, treated and then re-injected under different conditions. The treatment of M1 under high pH or high temperature conditions accelerated the formation of M4, supporting that the C-demethylated metabolite was generated by the non-enzymatic decarboxylation of M1 (Fig. 3) .
The oxadiazole ring attached to the tert-butyl moiety supposedly contributes to the resonance, which stabilizes the electrons by conjugation, for decarboxylation of the tert- acid, is species-specific. The research on the enzyme(s) involved in carboxyl formation is on progress to identify which enzyme reaction is species-specific.
In conclusion, LC15-0133 was metabolized to a carboxylic acid metabolite, via an alcohol metabolite, by rat microsomal enzyme, which subsequently decarboxylated to yield a demethylated metabolite at the tert-butyl moiety. This unusual C-demethylation reaction was thought to occur due to the resonance stabilization due to the oxadiazole ring attached to the tert-butyl moiety. 385, 357, 313, 285, 263, 228 M3 8.5 387 369, 340, 315, 258, 173. 143 M4 10.3 357 339, 285, 267, 228, 173, 113 M5 10.7 373 355, 301, 283, 244, 214, 175, 157 M6 10.7 373 355, 301, 283, 244, 214, 175, 157 This article has not been copyedited and formatted. The final version may differ from this version. 
